Topic: National Eye Institute
New York-Glaucoma may be the second leading cause of blindness, but millions of people around the world at risk for the disease still do not get simple, routine screenings that could save their eyesight. That's why the World Glaucoma Association and the ...
To recognize the second annual World Glaucoma Day (WGD), the Association for Eye and Vision Research (AEVR) sponsored a March 10 Capitol Hill briefing to educate Members of Congress and their staffs. In introducing the briefing, AEVR Executive Director James Jorkasky read ...
New York-Glaucoma may be the second leading cause of blindness, but millions of people around the world at risk for the disease still do not get simple, routine screenings that could save their eyesight. That's why the World Glaucoma Association and the ...
Laser therapy is a safe and effective alternative to eyedrops as a first-line treatment for patients with newly diagnosed primary open-angle glaucoma, according to research results released today. The finding comes from a followup study of patients in the nationwide Glaucoma Laser ...
During Glaucoma Awareness Month in January, the National Eye Health Education Program (NEHEP) Partnership, coordinated by the National Eye Institute (NEI), is highlighting the medical advances for glaucoma that have been developed during the past five years. "These therapies effectively treat glaucoma ...
The Glaucoma Laser Trial (GLT), sponsored by the National Eye Institute of the National Institutes of Health, is being conducted at 11 centers including eight clinics. Moreover, open-angle glaucoma is the most common form of glaucoma in the United States, and a ...
"This study showed that treating elevated eye pressure delays or prevents the onset of glaucoma in some people," said Paul A. Sieving, M.D., Ph.D., director of the National Eye Institute (NEI), a component of the Federal government's National Institutes of Health (NIH) ...
Researchers supported by the National Institutes of Health have discovered that black and white patients with advanced glaucoma respond differently to two surgical treatments for the disease. "This is the first evidence that members of two racial groups benefit from different treatments ...
NEI Information Office Telephone: The study was funded by the National Eye Institute (NEI) and the National Center on Minority Health and Health Disparities (NCMHD), two components of the Federal government's National Institutes of Health. "This is the first study to recruit ...